Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “High-risk Tumor”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Testing effectiveness (Phase 2)Study completedNCT00290498
What this trial is testing

Study of Rituximab-HCVAD Alternating With Rituximab-Methotrexate-Cytarabine Versus Standard Rituximab-CHOP Every 21 Days for Patients With Newly Diagnosed High Risk Aggressive B-Cell Non-Hodgkin's Lymphomas in Patients 60 Years Old or Younger

Who this might be right for
Lymphoma
M.D. Anderson Cancer Center 67
Early research (Phase 1)Ended earlyNCT05209152
What this trial is testing

AMG 176 With Azacitidine in Subjects With Myelodysplastic Syndrome /Chronic Myelomonocytic Leukemia

Who this might be right for
Higher Risk Myelodysplastic SyndromeChronic Myelomonocytic Leukemia
Amgen 7
Testing effectiveness (Phase 2)Study completedNCT00047021
What this trial is testing

Combination Chemotherapy in Treating Patients With Recurrent or Refractory Leukemia or Lymphoma

Who this might be right for
LeukemiaLymphoma
Case Comprehensive Cancer Center 3
Large-scale testing (Phase 3)Study completedNCT02923258
What this trial is testing

Postoperative CCRT With Docetaxel vs Cisplatin in High Risk Oral Cavity Cancer

Who this might be right for
Oral Cavity Squamous Cell Carcinoma
Shanghai Ninth People's Hospital Affiliated to Shanghai Jiao Tong University 224
Early research (Phase 1)Study completedNCT02364492
What this trial is testing

A Phase I Study of a Therapeutic Vaccine Candidate in Patients With Localized Breast Cancer at High-Risk of Relapse

Who this might be right for
Breast Neoplasms
Institut Pasteur 20
Early research (Phase 1)UnknownNCT06551233
What this trial is testing

Safety and Efficacy of 9MW2821 in the Treatment of High-risk Non-muscle-invasive Bladder Cancer (NMIBC)

Who this might be right for
Bladder Cancer
The Affiliated Nanjing Drum Tower Hospital of Nanjing University Medical School 30
Testing effectiveness (Phase 2)Study completedNCT01560949
What this trial is testing

Preoperative Folfirinox, Radiation Therapy for Resectable Adenocarcinoma of the Pancreas

Who this might be right for
Pancreatic Cancer
M.D. Anderson Cancer Center 34
Not applicableActive Not RecruitingNCT04276532
What this trial is testing

Sentinel Lymph Node Sampling for Patients With Middle-high Risk Endometrial Cancer Confined to the Uterus

Who this might be right for
Middle-high Risk Endometrial CancerSentinel Lymph Node SamplingPrognosis
Xiaojun Chen 780
Large-scale testing (Phase 3)UnknownNCT03025893
What this trial is testing

A Phase II/III Study of High-dose, Intermittent Sunitinib in Patients With Recurrent Glioblastoma Multiforme

Who this might be right for
Glioblastoma MultiformeGlioblastoma, AdultGlioblastoma+2 more
Amsterdam UMC, location VUmc 100
Testing effectiveness (Phase 2)WithdrawnNCT03226236
What this trial is testing

Vaccination With Dendritic Cells Pulsed With Autologous Tumor Homogenate in Combination With HD-IL2 and Immunomodulating Radiotherapy in Metastatic RCC

Who this might be right for
Carcinoma, Renal CellVaccinationSecondary
Istituto Romagnolo per lo Studio dei Tumori Dino Amadori IRST S.r.l. IRCCS
Very early researchStudy completedNCT04298606
What this trial is testing

A Vaccine (CIMAvax-EGF) for the Prevention of Lung Cancer Development or Recurrence

Who this might be right for
Chronic Obstructive Pulmonary DiseaseLung Non-Small Cell CarcinomaPneumonia+5 more
Roswell Park Cancer Institute 20
Not applicableNot Yet RecruitingNCT07805434
What this trial is testing

AI-Based Personalized Digital Management for High-Risk Pulmonary Nodule Follow-up

Who this might be right for
Pulmonary Nodules
The First Affiliated Hospital of Guangzhou Medical University 4,000
Testing effectiveness (Phase 2)Looking for participantsNCT01804634
What this trial is testing

Reduced Intensity Haploidentical BMT for High Risk Solid Tumors

Who this might be right for
Refractory and/or Relapsed Metastatic Solid Tumors
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins 60
Large-scale testing (Phase 3)Ended earlyNCT04752332
What this trial is testing

Abemaciclib (LY2835219) Plus Hormone Therapy in Participants With Early Breast Cancer

Who this might be right for
Breast Neoplasms
Eli Lilly and Company 111
Not applicableLooking for participantsNCT07806604
What this trial is testing

Real World Study of Icotinib in Adjuvant Post Surgical Treatment for Stage IA2 High Risk to IB EGFR Mutant Non Small Cell Lung Cancer

Who this might be right for
NSCLC (Non-small Cell Lung Cancer)
Betta Pharmaceuticals Co., Ltd. 2,572
Early research (Phase 1)Active Not RecruitingNCT05768347
What this trial is testing

Intravesical Adoptive Cell Therapy w/ TIL for BCG Exposed High Grade NMIBC

Who this might be right for
Urothelial CarcinomaNon-Invasive Bladder Urothelial Carcinoma
H. Lee Moffitt Cancer Center and Research Institute 9
Large-scale testing (Phase 3)UnknownNCT04536558
What this trial is testing

Olanzapine Plus Fosaprepitant Standard Antiemetic Therapy in the Prevention of Chemotherapy-induced Nausea and Vomiting in Patients Receiving High Emetic Risk Multi-day Chemotherapy: a Multicenter, Randomized, Double-blind, Placebo-controlled, Phase 3 Study

Who this might be right for
Solid Tumor Patients Receiving High Emetic Risk Multi-day Chemotherapy
Sun Yat-sen University 352
Not applicableEnded earlyNCT00966498
What this trial is testing

Peripheral Blood Stem Cell Transplant (PBSCT) in Children With High Risk or Recurrent Solid Tumors

Who this might be right for
High Risk Solid TumorsRecurrent Solid Tumors
Emory University 3
Testing effectiveness (Phase 2)UnknownNCT00280930
What this trial is testing

Letrozole in Postmenopausal Women at Increased Risk for Breast Cancer

Who this might be right for
Post-MenopausalBreast Cancer
Dana-Farber Cancer Institute 60
Testing effectiveness (Phase 2)Study completedNCT00144807
What this trial is testing

ACVBP Plus Rituximab in Patients Aged From 18 to 59 Years With High-risk Diffuse Large B-cell Lymphoma

Who this might be right for
Diffuse Large Cell Lymphoma
Lymphoma Study Association 128
Next Page